Name
›
Address/P.O. Box
›
Postal Code/City Country Contact Person Telephone Email Website Social Media Number of Employees Founded (year) Areas of Activity
Eurasanté
›
Parc Eurasanté Ouest – 310, avenue Eugène Avinée 59120, Loos France Caroline Auberger +33-3-28-55-90-60 cauberger@eurasante.com https://lille.eurasante.com/
›
LI
› › › › ›
› ›
›
111 1994 | Innovation | Technology transfer | Business development | Life sciences | Health | Nutrition
Eurasanté, one of the best innovative hubs for biotech in Europe Eurasanté is a technology transfer tool, an incubator, an accelerator, and a cluster manager in the Life Sciences sector in Northern France. Eurasanté assists French and foreign companies, entrepreneurs, scientists, and clinicians in their innovation and development projects in the Northern France region. The region includes over 1,100 healthcare companies with 32,000 employees in this sector. Their strengths are in neurodegenerative diseases, medical chemistry, and nutrition. Eurasanté also promotes and develops the Eurasanté Bio-business Park, which hosts 8 hospitals, 4 universities, 7 specialised schools, 200 companies, and 50 laboratories within a European-wide scientific and medical site. Eurasanté fosters technology transfer and collaborative projects and supports the emergence of start-ups and spin-offs. Two programmes have been created to stimulate the creation of start-ups in the biotechnology sector: the Eurasanté Bio Incubator and Bio-Accelerator. They provide a range of services and expertise to help international start-ups wishing to penetrate the European healthcare market and to join an ecosystem among the most fertile in Europe. The Eurasanté Bio Incubator is ranked among the top 25 best European incubators fostering biotech start-up development (Labiotech.eu 2021). Since its creation in 2000, it has accompanied 260 projects, helped the creation of 140 start-ups that generated 1,300 jobs, and raised €670 million in equity. Eurasanté facilitates the relocation of companies, whether they plan to expand or begin new activities in France, and gives access to investment funds dedicated to innovative start-ups: CAPTECH SANTE NUTRITION and French Tech Seed. These investment funds strengthen co-investment. For biotech start-ups wishing to start clinical trials, the funding needs can be supported through new fundraising, closed thanks to the public and private investors involved in the investment funds.
